5-methyl-2'-fluoroarauracil F-18 is under investigation in clinical trial NCT02809690 (18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.